ZURICH, Switzerland, Dec. 21, 2005 (PRIMEZONE) -- Nobel Biocare (Other OTC:NBCHF) (Stockholm:NOBE), the world leader in innovative esthetic dental solutions, this week won four prestigious Townie Choice Awards in the categories for Implant Systems, Implant Accessories and Implant Accessories Restorative, as well as for the category for Post-Graduate Training Institutes.
Nobel Biocare's NobelDirect, NobelReplace and Branemark implant systems won in the Implant Systems category. This marks the second year in a row that Nobel Biocare implant systems placed far ahead of other implant manufacturers such as Straumann, 3i, Astra Tech and Camlog. In the category for Implant Accessories, Nobel Biocare's Replace Select was voted number one. For the category of Implant Accessories Restorative, the CAD/CAM designed Procera Abutment Zirconia, along with Nobel Biocare's Snappy Abutment and Easy Abutment, received top honors from laboratories and clinicians.
Heliane Canepa, President and CEO of Nobel Biocare said, "Winning the Townie Choice Awards is a strong vote of confidence from the dental professionals."
The Townie Choice Awards is an independent survey developed and run by Dentaltown.com, Inc. Nearly 60,000 members of www.dentaltown.com including specialists, general practitioners, hygienists, and students were able to vote.
NOBEL BIOCARE HOLDING AG
Nobel Biocare is a medical devices group and the world leader in innovative esthetic dental solutions with its brands Branemark System(r), NobelSpeedy(tm), NobelReplace(tm), NobelPerfect(r), NobelDirect(r), Replace(r) Select, (dental implants) and Procera(r) (individualized dental prosthetics). Nobel Biocare is a one-stop shop for restorative esthetic dentistry, offering a wide range of innovative crown and bridge and implant products, as well as training and education and clinically documented treatment concepts. Nobel Biocare has some 1,600 employees and recorded revenue of EUR 388 million in 2004. The company is domiciled in Zurich, Switzerland with headquarters in Zurich and in Gothenburg, Sweden. Production takes place at four production sites located in Sweden and the USA. Nobel Biocare has direct sales organizations in 29 countries. The shares of the parent company Nobel Biocare Holding AG are listed on the SWX Swiss Exchange and on the Stockholm Stock Exchange, Sweden.
Celebrating 40 years of scientific heritage. In 1965, the first patient was treated with the original scientific dental implant system, the Branemark System(r). This event marked a breakthrough in modern dental implant therapy. Since then, millions of people have been helped with dental implants, enjoying improved function, appearance and quality of life. The original fixtures that were placed in the first patient 40 years ago are still in place, providing the individual with firm bridge support. The Branemark System(r) has been scientifically documented in 1,500 articles.